Changyan Ma

8PUBLICATIONS
4CO-AUTHORS
BiomaterialsCancer diagnosisMechanobiologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 05, 2024
KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc.

Bing Yao, Mengying Xing, Xiangwei Zeng

|Nov 28, 2023
EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN.

Bing Yao, Mengying Xing, Shixin Meng

|May 14, 2022
TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway.

Mengying Xing, Ying Yang, Jiaxue Huang

|May 04, 2021
MiR-664-3p suppresses osteoblast differentiation and impairs bone formation via targeting Smad4 and Osterix.

Yuexin Xu, Yucui Jin, Fangling Hong

Pageof 2